BL
Blau Farmaceutica
BLAU3.SA·BVMFCotia BRFounded 19872,500 employees
Small CappharmaPublicHematologyInfectious Disease
Platform: Specialty Heparin
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (BLAU3.SA)
Loading BLAU3.SA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Tezerelsin | BLA-7519 | Phase 1/2 | 2 | SOS1 | Crohn'sMCC | ||
| Mirinesiran | BLA-3209 | Preclinical | 1 | PARP | Huntington's |
SEC Filings & Financial Documents
SEC filings are not available for BVMF-listed companies.
Blau Farmaceutica trades on BVMF (BR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)